Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v1-EN
Language English English
Date Updated 2023-03-31 2023-03-08
Drug Identification Number 02246084 02246084
Brand name IPRAVENT IPRAVENT
Common or Proper name Ipravent Ipravent
Company Name AA PHARMA INC AA PHARMA INC
Ingredients IPRATROPIUM BROMIDE IPRATROPIUM BROMIDE
Strength(s) 42MCG 42MCG
Dosage form(s) SOLUTION SOLUTION
Route of administration NASAL NASAL NASAL NASAL
Packaging size 15ML 15ML
ATC code R01AX R01AX
ATC description DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2023-03-23 2023-03-23
Actual start date
Estimated end date 2023-04-26 2023-06-15
Actual end date 2023-03-30
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments